Related by context. All words. (Click for frequent words.) 72 hepatitis B infection 71 latent tuberculosis infection 71 HBV infections 70 CMV infection 67 chlamydial infection 66 CMV infections 66 adenomatous polyps 66 CMV disease 66 chronic HBV infection 65 EBV infection 65 seropositivity 65 coinfection 65 herpes infection 65 fluoroquinolone resistance 65 HCV infection 65 cytomegalovirus infection 65 HBV 65 herpes zoster shingles 64 LTBI 64 genital herpes infections 64 eosinophilic pneumonia 64 Candida infection 64 superinfection 64 candidemia 64 chlamydial 64 chronic HBV 64 cervical intraepithelial neoplasia 64 C. trachomatis 63 chronic HCV infection 63 VZV 63 chronic hepatitis cirrhosis 63 LCMV infection 63 T1DM 63 MGUS 63 HBeAg negative 63 hepatitis B virus HBV 63 invasive aspergillosis 63 HIV HCV coinfected 63 genital ulcers 63 immunosuppressed patients 63 cervical lesions 63 HPV infection 62 thromboembolic disease 62 Hepatitis B Virus 62 MRSA colonization 62 HBeAg 62 prostate cancer CaP 62 EXJADE 62 HER2 overexpression 62 G6PD deficiency 62 Chlamydia trachomatis 62 varicella infection 62 colorectal adenomas 62 NNRTI resistance 62 Neisseria gonorrhoeae 62 latent TB infection 62 serologic 62 antiviral therapy 62 HAV infection 62 nonvaccine 62 nephrotoxicity 62 HBsAg 62 chlamydia infection 62 acute GvHD 62 Candidiasis 62 varicella zoster virus VZV 62 Asymptomatic 62 colorectal cancer CRC 62 etiologic 62 VUR 62 renal scarring 62 N. gonorrhoeae 62 ADPKD 62 precursor lesions 62 viremia 62 adrenal suppression 62 endometrial hyperplasia 62 herpes zoster 62 Influenza vaccination 62 leukemia ALL 62 recurrent VTE 62 virologic failure 62 advanced adenoma 62 invasive candidiasis 62 S. aureus infections 62 renal toxicity 61 CIN2 + 61 rhinovirus infection 61 SIV infection 61 node metastases 61 de ath 61 H pylori 61 recurrent genital herpes 61 Genital herpes 61 postexposure prophylaxis 61 Chlamydia pneumoniae 61 non metastatic osteosarcoma 61 hepatic toxicity 61 Candida species 61 WNV infection 61 relapsed MM 61 androgen deprivation 61 proliferative diabetic retinopathy 61 severe oral mucositis 61 HCV infections 61 HeFH 61 invasive fungal infections 61 PTLD 61 APTIVUS r 61 pharmacokinetic interactions 61 elevated CRP 61 hepatitis C infection 61 anal HPV 61 PPSV# 61 CIN3 61 Pneumocystis carinii pneumonia 61 HCV infected 61 basal cell nevus syndrome 61 gastric adenocarcinoma 61 gastric carcinoma 61 H. pylori infection 61 hypersensitivity reaction 61 bacteraemia 61 systemic lupus erythematosus SLE 61 NOMID 61 imatinib therapy 61 latent tuberculosis 61 predisposing factors 61 pneumococcal infection 61 efalizumab 61 BCG vaccinated 61 chronic hepatitis 61 immunocompetent 60 chronic periodontitis 60 myeloproliferative neoplasms 60 AAT deficiency 60 Epstein Barr virus EBV 60 severe rotavirus gastroenteritis 60 pharmacologic intervention 60 cervical carcinoma 60 IUGR 60 subclinical 60 HAART 60 gonococcal infections 60 K ras mutations 60 M#V mutation 60 microalbuminuria 60 BRCA mutation 60 hypercalcemia 60 chlamydial infections 60 grade cervical intraepithelial 60 allogeneic HSCT 60 atypical ductal hyperplasia 60 intravenous bisphosphonates 60 GH deficiency 60 ribavirin therapy 60 T2DM 60 posaconazole 60 systemic fungal infections 60 sporadic Creutzfeldt Jakob 60 torsade de pointes 60 antimicrobial prophylaxis 60 chronic GVHD 60 bacterial vaginosis BV 60 squamous cell lung cancer 60 primary hyperparathyroidism 60 KETEK 60 metastatic RCC 60 antiretroviral naive 60 combination antiretroviral therapy 60 hepatorenal syndrome 60 sustained virological response 60 acute GVHD 60 HIV coinfected 60 atopic disease 60 lichen planus 60 HSCT 60 SLNB 60 HNSCC 60 allograft rejection 60 Pseudomonas aeruginosa infections 60 prostate carcinogenesis 60 Plasmodium falciparum malaria 60 serotype #A 60 decompensated liver disease 60 prophylactic treatment 60 lenalidomide Revlimid R 60 secondary hyperparathyroidism 60 spontaneous preterm delivery 60 tumor recurrence 60 invasive meningococcal disease 60 amenorrhoea 60 HSV1 60 WNV infections 60 corticosteroid therapy 60 systemic scleroderma 60 hepatitis C virus 60 testicular germ cell 60 Adenomas 60 alcoholic hepatitis 60 parasitemia 60 empiric therapy 60 Vitamin D insufficiency 60 immunosuppressive therapies 59 atrophic gastritis 59 MULTAQ 59 HBeAg positive patients 59 coinfected 59 recurrent wheezing 59 sCJD 59 JAK2 enzyme 59 immunosuppressed 59 nonmelanoma skin cancer 59 MDR tuberculosis 59 elevated ALT 59 Chlamydia infection 59 tuberculin skin testing 59 genital ulcer 59 bronchopulmonary dysplasia 59 HIV seroconversion 59 plasma kallikrein 59 prostate adenocarcinoma 59 metastatic malignant 59 bacterial vaginosis 59 respiratory viral infections 59 lupus nephritis 59 intensive statin therapy 59 Chlamydia infections 59 S. aureus infection 59 genital lesions 59 BCR ABL mutations 59 Trichomonas vaginalis 59 Cryptococcus neoformans 59 immunosuppressant therapy 59 asymptomatic carriers 59 glucocorticoid therapy 59 cervicitis 59 diabetic kidney 59 neoplasia 59 trimethoprim sulfamethoxazole 59 neoplastic 59 SGPT 59 hyperprolactinemia 59 hepatitis C HCV 59 orchitis 59 juvenile idiopathic arthritis JIA 59 trichomonas 59 elevated triglyceride levels 59 NRTI resistance 59 NAbs 59 suppressive therapy 59 hypereosinophilic syndrome 59 N. meningitidis 59 IgA deficiency 59 PCa 59 recurrent UTI 59 BRCA mutations 59 β blockers 59 plasma viremia 59 cirrhosis liver failure 59 myeloproliferative diseases 59 COPD exacerbations 59 neurocognitive impairment 59 BARACLUDE ® 59 glycated hemoglobin levels 59 vWD 59 thyroid dysfunction 59 S. aureus colonization 59 testicular tumors 59 hyperparathyroidism 59 hereditary antithrombin deficiency 59 Leukemias 59 postexposure 59 keloid formation 59 imatinib resistance 59 type 1diabetes 59 chemoprophylaxis 59 mitochondrial toxicity 59 Hepatotoxicity 59 LQTS 59 postoperative AF 59 SSc 59 severe neutropenia 59 Severe Primary IGFD 59 leukemia AML 59 EGFR mutation 59 asymptomatic 59 somatostatin analogs 59 Thrombocytopenia 59 precancerous cervical lesions 59 renal transplantation 59 gonococcal infection 59 ASCUS 59 CDAD 59 endotoxemia 59 antibiotic prophylaxis 59 genital ulcer disease 59 onset diabetes mellitus 59 pulmonary hypertension PH 59 hematological parameters 59 pheochromocytoma 59 hepatocellular carcinoma 59 serum creatinine levels 59 HPV-#/# 59 Opportunistic infections 59 hepatotoxicity 59 recurrent glioblastoma multiforme 59 HIV infection 59 HCV antibody 59 Ribavirin causes 59 NAFLD 59 CCR5 tropic 59 HIV seropositive 59 penicillin allergy 59 CMV reactivation 59 microscopic hematuria 59 advanced neoplasia 59 bronchopulmonary dysplasia BPD 59 cytomegalovirus CMV 59 hypercalciuria 59 PREZISTA r 59 Antiretroviral therapy 59 posttransplant 59 endophthalmitis 59 oesophageal adenocarcinoma 59 reproductive tract infections 59 Recombinant interferon alpha 59 APOE e4 59 ocular toxicity 59 relapsing remitting MS RRMS 59 pathologic fractures 59 selenium supplementation 59 acute leukemias 59 vivax 59 tigecycline 59 hemorrhagic complications 59 GIST tumors 59 antibody titer 59 thrombophilia 59 cryptococcal meningitis 59 tumor lysis syndrome 59 enteroviral infection 59 P. falciparum malaria 59 postoperative pulmonary 58 seroconversion 58 BRCA2 gene mutation 58 HPV infections 58 nucleoside analogues 58 hepatic function 58 histologic subtype 58 Natalizumab 58 transaminase levels 58 Vitamin B# deficiency 58 dermatophytes 58 plasma pharmacokinetics 58 acute gout flares 58 HBeAg positive 58 colonoscopy sigmoidoscopy 58 GABHS 58 invasive fungal infection 58 vesicoureteral reflux 58 adenovirus infections 58 venous blood clots 58 hepatic fibrosis 58 bacteriuria 58 latent tuberculosis TB 58 immunological responses 58 HCV genotype 58 herpes zoster virus 58 candidiasis 58 colorectal adenoma 58 transferrin saturation 58 leukoencephalopathy 58 dopaminergic therapy 58 juvenile idiopathic arthritis 58 Microalbuminuria 58 polyp recurrence 58 Hib disease 58 colorectal adenocarcinoma 58 transfusion transmitted 58 acute rheumatic fever 58 malignant neoplasms 58 lamivudine resistant 58 Helicobacter pylori H. pylori 58 metastatic neuroendocrine tumors 58 hypovitaminosis D 58 HCV 58 fetal malformations 58 riociguat 58 myopathy rhabdomyolysis 58 RSV infections 58 abnormal vaginal bleeding 58 familial pancreatic cancer 58 varicella zoster virus 58 erythema nodosum 58 hereditary predisposition 58 myeloproliferative disorders 58 B7 H3 58 Latent TB 58 psoriatic arthritis PsA 58 immune reconstitution syndrome 58 cervical vaginal 58 indinavir 58 coinfections 58 serologic testing 58 SHPT 58 Hashimoto thyroiditis 58 AA Amyloidosis 58 prolonged QT interval 58 Acute Bacterial Sinusitis ABS 58 HPV subtypes 58 syndromic 58 germline mutations 58 motor neuron degeneration 58 AUDs 58 subclinical hypothyroidism 58 cTnT 58 virological response 58 chronic eosinophilic leukemia 58 urethritis 58 Thyroid disorders 58 basal cell carcinoma BCC 58 CP CPPS 58 multidrug resistance 58 simplex virus 58 untreated celiac disease 58 herpes zoster vaccine 58 precancerous condition 58 haloperidol Haldol 58 cisplatin chemotherapy 58 thromboembolic complications 58 haematopoietic 58 virus HBV 58 S. aureus bacteremia 58 aminotransferase levels 58 thrombotic events 58 hypercholesterolaemia 58 intrauterine infection 58 Hydroxyurea 58 oral mTOR inhibitor 58 infective endocarditis 58 hepatitis B HBV 58 falciparum 58 diabetes mellitus DM 58 atherothrombotic disease 58 Enterobacteriaceae 58 renal allograft 58 androgen suppression 58 NPM1 mutation 58 abnormal Pap smear 58 Hepatocellular Carcinoma HCC 58 Tindamax R 58 cMET 58 lupus anticoagulant 58 herpes infections 58 Nilotinib 58 prednisone prednisolone 58 UGT#A# * 58 Candida infections 58 anti JCV antibodies 58 arterial calcification 58 antiphospholipid antibodies 58 S aureus 58 coagulation abnormalities 58 presymptomatic 58 CMV retinitis 58 subclinical hyperthyroidism 58 gonococcal 58 ovarian hormones 58 nucleotide analog 58 β blocker 58 Bronchiectasis 58 Hematologic 58 tumor necrosis 58 immunopathology 58 histological subtype 58 subclinical disease 58 PAOD 58 CYT# potent vascular disrupting 58 enterovirus infection 58 Staphylococcus aureus infections 58 danazol 58 perinatal transmission 58 chronic granulomatous disease 58 Bcr Abl mutations 58 poor metabolizers 58 Liver transplantation 58 heavily pretreated 58 herpesviruses 58 venous thromboembolic events 58 psychiatric morbidity 58 potentially modifiable 58 undergoing radical prostatectomy 58 heterozygous FH 58 HER2 expression 58 metastatic gastric 58 PSA nadir 58 disease progression 58 thrombotic complications 58 Chronic Hepatitis C 58 FVIII inhibitors 58 HBeAg seroconversion 58 severe hyperbilirubinemia 58 canakinumab 58 antiplatelet medications 58 lactic acidosis 58 androgen deficiency 58 sustained virologic response 58 periodontitis 58 Acute Radiation Syndrome ARS 58 biochemical recurrence 58 autoimmune thyroid 58 lipohypertrophy 57 allogeneic transplantation 57 virological failure 57 cancerous cervical lesions 57 mediated immunity 57 relapsed ovarian cancer 57 chorioamnionitis 57 immunodeficiency 57 Cariprazine 57 Valcyte 57 allogeneic bone marrow 57 ALT flares 57 biologic DMARD 57 APOE genotype 57 Actinic Keratosis 57 COPD exacerbation 57 mycophenolate mofetil 57 empiric treatment 57 Barrett esophagus BE 57 virologic responses 57 TMP SMX 57 Pelvic Inflammatory Disease 57 cytopathic 57 HBV DNA 57 Chlamydia trachomatis infection 57 psychiatric comorbidity 57 HPV genotypes 57 adrenal insufficiency 57 serum phosphate 57 atherothrombotic events 57 hydroxychloroquine 57 essential thrombocythemia 57 atypical femur fractures 57 SIMPONI ® 57 tipranavir ritonavir 57 pH#N# 57 Onychomycosis 57 leiomyomas 57 Clusterin 57 GISTs 57 hepatocellular carcinoma HCC 57 colorectal carcinoma 57 atherosclerotic disease 57 lupus erythematosus 57 dysglycemia 57 Nicotine dependence 57 venous thromboembolic disease 57 lymphocytosis 57 HAART regimens 57 squamous intraepithelial lesions 57 salmeterol HFA MDI 57 abnormal pap smears 57 Human Papillomavirus 57 neurocognitive deficits 57 shorter telomere length 57 nonalcoholic steatohepatitis 57 nonmelanoma skin cancers 57 external genital lesions 57 M. leprae 57 HbF 57 gallstone disease 57 Squamous 57 Acute myeloid leukemia 57 tuberculous 57 receiving VELCADE 57 pyrimethamine 57 Escherichia coli Klebsiella pneumoniae 57 TNF antagonist 57 TNF blocker therapy 57 mediastinitis 57 artemisinin resistance 57 Fatty Liver Disease 57 Hepatitis B virus 57 FASLODEX 57 serum folate concentrations 57 familial adenomatous polyposis 57 prostatic hyperplasia 57 CTAP# Capsules 57 Progressive Multifocal Leukoencephalopathy 57 transgene expression 57 TP# mutations 57 methotrexate therapy 57 cerebral vasospasm 57 HPV# 57 nonvaccine serotypes 57 atherosclerotic CVD 57 post thrombotic syndrome 57 atypical antipsychotic medications 57 falciparum malaria 57 Chronic Myeloid Leukemia 57 initiating antiretroviral therapy 57 apolipoprotein E4 57 heparin induced thrombocytopenia 57 perioperative complications 57 immunosuppression 57 facial clefts 57 humoral responses 57 adalimumab Humira 57 MALT lymphoma 57 oropharyngeal cancer 57 chronic hepatitis B 57 upper gastrointestinal bleeding 57 detectable HCV RNA 57 acute humoral rejection 57 mtDNA mutations 57 BMPR2 57 pelvic lymphadenectomy 57 comorbid disorders 57 asymptomatic bacteriuria 57 neurosyphilis 57 lipid abnormalities 57 platelet reactivity 57 PCNSL 57 iron supplementation 57 contrast induced nephropathy 57 Human papillomavirus HPV 57 AML MDS 57 acute myelogenous leukemia AML 57 aminotransferases 57 endometriosis ovarian cysts 57 breast endometrial 57 atherothrombosis 57 Periodontitis 57 P aeruginosa 57 serum PTH 57 Treg cell 57 anti HBs 57 cervical vulvar 57 chronic hepatitis B. 57 Cytomegalovirus CMV 57 Cholangiocarcinoma 57 colorectal neoplasia 57 Telbivudine 57 ziconotide 57 Cethromycin 57 HIV uninfected 57 Prostatitis 57 hemorrhagic cystitis 57 polycythemia vera PV 57 serum lipid levels 57 pneumococcal vaccination 57 PSADT 57 hereditary hemochromatosis 57 BCG refractory 57 microvascular disease 57 polyomavirus nephropathy 57 LRP5 57 atherosclerotic progression 57 streptococcal infections 57 LHRH analogues 57 FluCAM arm 57 adalimumab 57 CCR5 delta# 57 BRAF mutations 57 leukemia CLL 57 precancerous cervical 57 chemopreventive agent 57 SOX3 gene 57 depressive symptomatology 57 iron overload 57 BRAF mutation 57 sodium stibogluconate 57 neoplasia PIN 57 tumorigenicity 57 LHRH antagonists 57 bacterial sepsis 57 glucocorticoid induced osteoporosis 57 LHRH agonists 57 Streptococcus pneumoniae pneumococcus 57 Raptiva ® 57 prognostic indicator 57 Kaposi sarcoma 57 urate levels 57 pneumococcal pneumonia 57 monoclonal gammopathy 57 gemifloxacin 57 KRAS mutation 57 endometrial carcinoma 57 liver decompensation 57 thalidomide Thalomid 57 vaccinees 57 reinfection 57 protease inhibitors PIs 57 CVD mortality 57 minimally symptomatic 57 hepatic failure 57 thyrotropin levels 57 mycophenolate mofetil MMF 57 axillary node 57 rheumatoid factor 57 atherogenic dyslipidemia 57 papillary renal cell carcinoma 57 virologic response 57 superficial bladder cancer 57 chloride secretion 57 acute aortic dissection 57 nitazoxanide 57 Zavesca ® 57 epithelial tumors 57 intraventricular hemorrhage 57 staphylococcal infections 57 vitamin D insufficiency 57 latently infected 57 malaria endemic regions 57 susceptible isolates 57 antineoplastic 57 trastuzumab Herceptin ® 57 atypia 57 neurodevelopmental outcome 57 potentially hepatotoxic 57 GnRH agonists 57 TTR amyloidosis 57 unknown etiology 57 NMIBC 57 GnRH agonist 57 Hypotension 57 chronic HCV 57 periodontal bacteria 57 pyrazinamide 57 neoplasias 57 Exacerbations 57 AST ALT 57 MYH9 gene 57 familial predisposition 57 Recurrences 57 infectious mononucleosis 57 peginterferon 57 androgen excess 57 immunocompromised patients 57 viraemia 57 NNRTI 57 Non Alcoholic Fatty 57 postoperative delirium 57 nosocomial pneumonia 57 grade cervical dysplasia 57 LVNC 57 invasive cervical cancer 57 antifungal therapy 57 mesotheliomas 57 placental malaria 57 transaminase elevations 57 genotypic resistance 57 prenatal exposures 57 malignant lymphoma 57 malignant transformation 57 immunosuppressive agents 57 HPAI H#N# 57 breast carcinoma 57 Myocardial infarction 57 impair fertility 57 abnormal lipid 57 seropositive patients 57 renal dysfunction 57 skeletal metastases 57 perianal 57 noninfectious uveitis 56 hyperglycaemia 56 abnormal cytology 56 HIVAN 56 Babesia 56 vitamin D inadequacy 56 selective modulator 56 SJIA 56 Epstein Barr Virus EBV 56 methicillin susceptible Staphylococcus aureus 56 Heavy menstrual bleeding 56 nutlin 3a 56 choroidal neovascularization 56 Epratuzumab 56 dysplastic lesions 56 STELARA ® 56 serum leptin 56 erlotinib Tarceva ® 56 serum aminotransferase levels 56 anal cancers 56 lobular carcinoma 56 nosocomial infection 56 subfertility 56 APOE ε4 56 diabetic nephropathy 56 myelofibrosis polycythemia vera 56 Toxicities 56 breast cancer metastasis 56 vaginal cancers 56 anthracycline taxane 56 proctitis 56 Chlamydia psittaci 56 familial ALS 56 fosamprenavir 56 Raf MEK ERK 56 hematopoietic cancers 56 serum urate levels 56 QTc interval 56 Mycoplasma pneumoniae 56 clinically asymptomatic 56 hepatic steatosis 56 zoster 56 specific antigen PSA 56 antioxidant supplementation 56 MGd 56 secondary amenorrhea 56 TTR gene 56 IDH mutations 56 thromboembolic 56 S. aureus isolates 56 adjuvant radiotherapy 56 mRCC 56 virologic 56 imipenem 56 FGFR2 56 thyrotoxicosis 56 transplantation HCT 56 premalignant lesions 56 urolithiasis 56 malignant lymphomas 56 Infected Patients 56 Ectopic pregnancy 56 oseltamivir resistance 56 systemic lupus erythematosus 56 asthma exacerbation 56 H. influenzae 56 thromboembolic events 56 voriconazole 56 BRCA2 mutations 56 ORENCIA ® 56 Helicobacter pylori infection 56 liver histology 56 TEAEs 56 chronic rhinosinusitis 56 hematologic toxicity 56 obstructive lung 56 receiving antiretroviral therapy 56 HGPIN 56 Hepatitis C virus 56 spontaneous preterm birth 56 symptomatic hyponatremia 56 neuroblastoma tumors 56 rotavirus diarrhea 56 renal insufficiency 56 Cytomegalovirus 56 haematologic 56 tryptase 56 overt nephropathy 56 distant metastases 56 chemoresistant 56 congenital deficiency 56 ESBLs 56 latent infection 56 radioiodine therapy 56 lumbar disc disease 56 rebleeding 56 cervical HPV 56 ritonavir boosted 56 fetal chromosomal 56 ATTR CM 56 Febrile neutropenia 56 Naive Patients 56 Human papillomavirus 56 zidovudine AZT 56 Brugada syndrome 56 cardiac repolarization 56 discontinued Viread 56 Marburg virus infection 56 seroprevalence 56 neutropenic patients 56 replicon 56 protease inhibitor PI 56 hyperphosphatemia 56 cholangiocarcinoma 56 epididymitis 56 oral thrush 56 disease CDAD 56 renovascular hypertension 56 Viral infections 56 perioperatively 56 refractory gout 56 mucinous 56 dyslipidaemia 56 neonatal sepsis 56 atypical hemolytic uremic syndrome 56 calcineurin inhibitors 56 P falciparum 56 Venous thromboembolism 56 Malignant Melanoma 56 ano genital warts 56 IgM antibodies 56 pandemic influenza virus 56 serum calcium levels 56 co trimoxazole 56 Polycythemia vera 56 Gorlin syndrome 56 dermatologic reactions 56 Anaplasma 56 APTIVUS ritonavir 56 UGT#A# 56 C1 INH deficiency 56 peginterferon alfa 2a 56 invasive pneumococcal disease 56 intracranial hemorrhage ICH 56 gastrointestinal stromal tumors GIST 56 promoter methylation 56 nonalcoholic steatohepatitis NASH 56 NATRECOR ® 56 immunomodulatory therapy 56 atherothrombotic 56 pneumococci 56 perfusion abnormalities 56 carcinoid tumors 56 androgen receptor AR 56 serum estradiol 56 pulmonary exacerbations 56 bisphosphonate therapy 56 Toxoplasmosis 56 serum concentrations 56 Relapsing remitting MS 56 disease NAFLD 56 cervical neoplasia 56 PsA 56 choriocarcinoma 56 CCP antibodies 56 bexarotene 56 chemosensitivity 56 pharyngeal cancer 56 biochemical relapse 56 airway hyperresponsiveness 56 renal cell carcinomas 56 paroxysmal AF 56 deletion 5q 56 IGRAs 56 protozoal 56 NP CRNs 56 serum IgE 56 hyperbilirubinemia 56 hydroxyvitamin D levels 56 HBV vaccine 56 colorectal tumors 56 quinolone 56 antibody titers 56 posterior uveitis 56 gestational hypertension 56 BRAF V#E mutation 56 Pegylated Interferon 56 trivalent inactivated influenza 56 Subgroup analyzes 56 gastric carcinogenesis 56 Hepatitis C Virus 56 lipid lowering therapies 56 rectal gonorrhea 56 hemagglutination inhibition HAI 56 hydatid disease 56 serum calcium 56 clinically heterogeneous 56 relapsed leukemia 56 liver fibrosis 56 R0 resection 56 complete cytogenetic response 56 prolactin levels 56 hypomagnesemia 56 Epidermal Growth Factor Receptor 56 systemic corticosteroids 56 Thyroid nodules 56 Golimumab 56 TGFBR1 * 6A 56 non Hodgkin lymphomas 56 malarial infections 56 bloodborne 56 lymphadenopathy 56 human metapneumovirus 56 primary aldosteronism 56 demyelinating 56 Soft Tissue Sarcoma 56 bacteremia 56 CD8 responses 56 esophageal candidiasis 56 SIMPONI TM 56 pT3 56 delayed CINV 56 immunocompromised individuals 56 erythropoietic 56 abdominal adiposity 56 autoantibody positive 56 relapsed ALL 56 cranial irradiation 56 follicular lymphoma FL 56 atopy 56 KRAS mutations 56 androgenetic alopecia